JBDS VRIII audit
As you will be aware the Joint British Diabetes Society (JBDS) guideline for the use of Variable Rate Intravenous Insulin Infusion (VRIII) was published in late 2014 and we hope it has become firmly embedded in practice in acute trusts throughout the country.
Link to guideline HERE
As with all JBDS publications though, this is a live document and with your help, we can make the next version and therefore the use of VRIII in medical inpatients, as safe as possible by using real world data about its use. We also want to get an idea of how many Trusts are using the guideline, and if not, the reasons for this and what local guidelines are being used in its place.
We have therefore launched a simple, quick, survey for you to use. It is completely anonymised - no patient level data is requested.
Please use the survey HERE. ‘A Survey of the Safety & Use of the Joint British Diabetes Service (JBDS) Guideline for the use of Variable Rate Intravenous Insulin Infusion for Medical Inpatients’:
We are asking you to enter the data for the NEXT 5 patients you come across in your day to day practice who are on a VRIII – this is to minimise selection bias. The survey reflects on the whole VRIII treatment, so please do not complete the survey until the patient has been stepped down for at least 24 hours.
Please save each patient survey file naming it according to NHS Trust name & patient survey number eg: East & North Herts NHS, survey 2 of 5 and then email it back to me at firstname.lastname@example.org
We hope to complete data collection by the end of August 2018.
Please do not use this for patients who had been treated for DKA.
Feel free to forward this on to your colleagues - the more data the better.
Don’t hesitate to contact me if you have any questions - or have technical glitches!
I look forward to receiving 5 files from each trust to the email address below in the near future!
Dr Stella George
Consultant Diabetes and Endocrinology
East and North Herts NHS Trust